On Thursday, Prothena Corporation plc (NASDAQ: PRTA) opened higher 1.82% from the last session, before settling in for the closing price of $6.32. Price fluctuations for PRTA have ranged from $4.32 to $25.42 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -3.15%. Company’s average yearly earnings per share was noted -70.39% at the time writing. With a float of $42.32 million, this company’s outstanding shares have now reached $53.83 million.
Let’s determine the extent of company efficiency that accounts for 163 employees. In terms of profitability, gross margin is 57.64%, operating margin of -100.49%, and the pretax margin is -84.0%.
Prothena Corporation plc (PRTA) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Prothena Corporation plc is 21.38%, while institutional ownership is 70.13%. The most recent insider transaction that took place on May 02 ’25, was worth 27,744,929. In this transaction 10% Owner of this company sold 3,317,938 shares at a rate of $8.36, taking the stock ownership to the 8,266,342 shares. Before that another transaction happened on May 06 ’25, when Company’s 10% Owner sold 1,984,053 for $7.64, making the entire transaction worth $15,164,712. This insider now owns 5,304,596 shares in total.
Prothena Corporation plc (PRTA) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -70.39% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -9.84% during the next five years compared to -3.15% drop over the previous five years of trading.
Prothena Corporation plc (NASDAQ: PRTA) Trading Performance Indicators
Check out the current performance indicators for Prothena Corporation plc (PRTA). In the past quarter, the stock posted a quick ratio of 9.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.08, a number that is poised to hit -1.22 in the next quarter and is forecasted to reach -2.58 in one year’s time.
Technical Analysis of Prothena Corporation plc (PRTA)
Looking closely at Prothena Corporation plc (NASDAQ: PRTA), its last 5-days average volume was 1.42 million, which is a jump from its year-to-date volume of 1.09 million. As of the previous 9 days, the stock’s Stochastic %D was 75.98%.
During the past 100 days, Prothena Corporation plc’s (PRTA) raw stochastic average was set at 17.13%, which indicates a significant decrease from 90.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 48.85% in the past 14 days, which was lower than the 81.95% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.60, while its 200-day Moving Average is $12.86. However, in the short run, Prothena Corporation plc’s stock first resistance to watch stands at $6.52. Second resistance stands at $6.61. The third major resistance level sits at $6.77. If the price goes on to break the first support level at $6.28, it is likely to go to the next support level at $6.12. Now, if the price goes above the second support level, the third support stands at $6.03.
Prothena Corporation plc (NASDAQ: PRTA) Key Stats
There are currently 53,827K shares outstanding in the company with a market cap of 346.38 million. Presently, the company’s annual sales total 135,160 K according to its annual income of -122,310 K. Last quarter, the company’s sales amounted to 2,830 K and its income totaled -60,200 K.
